NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 254 filers reported holding NATERA INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,137 | -9.4% | 6,037 | -0.4% | 0.00% | 0.0% |
| Q2 2023 | $294,831 | +18.9% | 6,059 | -0.5% | 0.00% | 0.0% |
| Q1 2022 | $248,000 | -49.8% | 6,090 | +15.2% | 0.00% | -50.0% |
| Q4 2021 | $494,000 | -10.8% | 5,285 | +6.3% | 0.00% | 0.0% |
| Q3 2021 | $554,000 | +0.2% | 4,972 | +2.0% | 0.00% | 0.0% |
| Q2 2021 | $553,000 | +16.4% | 4,873 | +4.1% | 0.00% | 0.0% |
| Q1 2021 | $475,000 | +9.7% | 4,682 | +7.7% | 0.00% | 0.0% |
| Q4 2020 | $433,000 | +148.9% | 4,348 | +80.7% | 0.00% | +100.0% |
| Q3 2020 | $174,000 | – | 2,406 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |